| Pieris Pharmaceuticals, Inc.. (9/10/18). "Press Release: Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil., to its Board of Directors". Boston, MA. |
2018-09-10 |
| Haplogen Bioscience GmbH. (9/10/18). "Press Release: Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases". Montréal, QC & Vienna. |
2018-09-10 |
| RSP Systems A/S. (9/10/18). "Press Release: RSP Systems Adds EUR 3.85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10.35 Million". Odense. |
2018-09-10 |
| Definiens AG. (9/10/18). "Press Release: Definiens Embarks on Digital Pathology Collaboration with Merck's Exploratory and Clinical Development Programs". Munich. |
2018-09-10 |
| Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. |
2018-09-09 |
| Medigene AG. (9/6/18). "Press Release: Medigene Announces Inclusion in SDAX". Planegg. |
2018-09-06 |
| Polyphor Ltd.. (9/6/18). "Press Release: Novo Holdings Invests CHF 6.8 Million in Polyphor to Accelerate the Development of Novel Antibiotics against Multi-drug Resistant Gram-negative Pathogens". Allschwil & Copenhagen. |
2018-09-06 |
| Evotec AG. (9/6/18). "Press Release: Evotec and Celgene Enter Partnership in the Field of Targeted Protein Degradation". Hamburg. |
2018-09-06 |
| Novartis AG. (9/6/18). "Press Release: Novartis to Divest the Sandoz US Dermatology Business and Generic US Oral Solids Portfolio to Aurobindo". Basel. |
2018-09-06 |
| Evotec AG. (9/6/18). "Press Release: Evotec AG Listed in MDAX". Hamburg. |
2018-09-06 |
| MorphoSys AG. (9/6/18). "Press Release: MorphoSys AG to Be Listed in MDAX". Planegg. |
2018-09-06 |
| Polyphor Ltd.. (9/6/18). "Press Release: Polyphor Announces Financial Results for the First Half 2018". Allschwil. |
2018-09-06 |
| Adocia S.A.. (9/5/18). "Press Release: Adocia Announces Positive Topline Results for the First Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. |
2018-09-05 |
| Minoryx Therapeutics S.L.. (9/5/18). "Press Release: Minoryx Therapeutics Announces Dosing of First US Patient in Phase 2/3 Clinical study of MIN-102 (ADVANCE)". Mataró, Barcelona. |
2018-09-05 |
| Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. |
2018-09-04 |
| NTrans Technologies B.V.. (9/4/18). "Press Release: NTrans Technologies Receives Horizon 2020 SME Grant". |
2018-09-04 |
| Miracor Medical S.A.. (9/4/18). "Press Release: Miracor Medical Closes Final Tranche of Series D, Bringing the Round to €30M". Awans. |
2018-09-04 |
| Pieris Pharmaceuticals, Inc.. (9/4/18). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy". Boston, MA. |
2018-09-04 |
| Probiodrug AG. (9/4/18). "Press Release: Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy". Halle (Saale). |
2018-09-04 |
| AiCuris Anti-infective Cures GmbH. (9/3/18). "Press Release: AiCuris Reports Positive Phase 1 Clinical Trial Results with Immunomodulator AIC649 in Patients with Chronic Hepatitis B". Wuppertal. |
2018-09-03 |
| Boehringer Ingelheim. (9/3/18). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Supports BeiGene in Its China NDA Submission of anti-PD-1 Antibody, Tislelizumab". Shanghai. |
2018-09-03 |
| Tecan Group Ltd.. (9/3/18). "Press Release: Tecan Successfully Completes the Acquisition of NuGen Technologies". Männedorf. |
2018-09-03 |
| Sanofi S.A.. (9/3/18). "Press Release: Cablivi (caplacizumab) Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. |
2018-09-03 |
| EuropaBio. (9/3/18). "Press Release: EuropaBio Appoints New Secretary General, Healthcare Director and Industrial Biotech Director". Brussels. |
2018-09-03 |
| BRAIN AG. (8/31/18). "Press Release: BRAIN AG Reports Growth for the First Nine Months of the 2017/18 Financial Year". Zwingenberg. |
2018-08-31 |
| Novartis Pharma GmbH. (8/31/18). "Pressemitteilung: Novartis und das Fraunhofer IZI geben Kooperation in der CAR-T Zelltherapie für Patienten in Europa bekannt". Leipzig & Nürnberg. |
2018-08-31 |
| Medigene AG. (8/31/18). "Press Release: Medigene Announces Change in Executive Leadership Team". Planegg. |
2018-08-31 |
| EMD Serono. (8/31/18). "Press Release: Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America". Rockland, MA. |
2018-08-31 |
| Lunaphore Technologies S.A.. (8/30/18). "Press Release: Lunaphore Closes a CHF 5.3M Series B Financing Round". Lausanne. |
2018-08-30 |
| BRAIN AG. (8/30/18). "Press Release: DOLCE Core Team Announces Membership Changes in Programme for Natural-based Sweeteners". Zwingenberg. |
2018-08-30 |
| Probiodrug AG. (8/30/18). "Press Release: Probiodrug Reports Financial Results for H1 2018 and Corporate Update". Halle (Saale). |
2018-08-30 |
| Alnylam Pharmaceuticals, Inc.. (8/30/18). "Press Release: Alnylam Receives Approval of Onpattro (patisiran) in Europe". Cambridge, MA. |
2018-08-30 |
| Enzymicals AG. (8/30/18). "Press Release: Enzymicals AG Extends Its Capacity in Business Development". |
2018-08-30 |
| Evotec AG. (8/30/18). "Press Release: Evotec and CHDI Foundation Extend Ongoing Collaboration to Fight Huntington’s Disease". Hamburg. |
2018-08-30 |
| EBD Group. (8/30/18). "Press Release: Global Life Sciences to Convene in Copenhagen for Europe's Largest Annual Biopharma Partnering Conference". Carlsbad, CA & Copenhagen. |
2018-08-30 |
| Bayer AG. (8/30/18). "Press Release: Bayer Receives US Approval for Modern Hemophilia A Treatment Jivi with a Step-wise Prophylaxis Dosing Regimen [Not intended for U.S. and UK Media]". Berlin. |
2018-08-30 |
| BMBF. (8/29/18). "Pressemitteilung: Startschuss für Agentur zur Förderung von Sprunginnovationen". |
2018-08-29 |
| Marinomed Biotech AG. (8/29/18). "Press Release: Vienna-based Biotech Company Marinomed on a Growth Path". |
2018-08-29 |
| Novartis AG. (8/29/18). "Press Release: European Commission Approves Novartis Combination Therapy Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600 Mutation-positive Melanoma". Basel. |
2018-08-29 |
| Novartis AG. (8/29/18). "Press Release: Alcon Announces Voluntary Global Market Withdrawal of CyPass Micro-Stent for Surgical Glaucoma". Basel. |
2018-08-29 |
| Nebula Genomics. (8/29/18). "Press Release: Nebula Genomics Raises $4.3M Seed Financing from Leading Tech and Biotech VCs". San Francisco, CA & Boston, MA. |
2018-08-29 |
| Roivant Sciences GmbH. (8/28/18). "Press Release: Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder". Basel & Irvine, CA. |
2018-08-28 |
| PhagoMed Biopharma GmbH. (8/28/18). "Press Release: Viruses against Bacteria. Development of Novel Therapeutics Boosted with Millions of Euros". Vienna. |
2018-08-28 |
| Apeiron Biologics AG. (8/28/18). "Press Release: Apeiron Expands Executive Board and Appoints Dr. Anderson Gaweco as Chief Medical and Scientific Officer (CMSO)". Vienna. |
2018-08-28 |
| Roche. (8/28/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. |
2018-08-28 |
| Affimed N.V.. (8/27/18). "Press Release: Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets". Heidelberg. |
2018-08-27 |
| Novartis AG. (8/27/18). "Press Release: Novartis Receives European Commission Approval of Its CAR-T Cell Therapy, Kymriah (tisagenlecleucel)". Basel. |
2018-08-27 |
| Evotec AG. (8/27/18). "Press Release: Evotec and Centogene Sign Global Strategic Partnership on Drug Discovery Projects in Rare Genetic Diseases". Hamburg & Rostock. |
2018-08-27 |
| Thermo Fisher Scientific Inc.. (8/27/18). "Press Release: Differential Ion Mobility Interface Boosts Proteomics Workflow Performance". Florence. |
2018-08-27 |
| British Heart Foundation. (8/25/18). "Press Release: £30m Global Challenge Launched to Tackle Heart and Circulatory Diseases". |
2018-08-25 |
| Eppendorf AG. (8/24/18). "Press Release: Control and Monitor up to 50 Cyclers from a Central Software Application". Hamburg. |
2018-08-24 |
| CMS. (8/24/18). "Pressemitteilung: Bruker Corporation erwirbt mit CMS Mehrheitsbeteiligung an Diagnostikunternehmen Hain Lifescience". Frankfurt a. M.. |
2018-08-24 |
| Nanion Technologies GmbH. (8/24/18). "Press Release: Nanion Technologies Opens New Office in Silicon Valley". Newark, CA. |
2018-08-24 |
| Bruker Corporation. (8/24/18). "Press Release: Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH". Billerica, MA. |
2018-08-24 |
| Bayer AG. (8/24/18). "Press Release: Bayer Secures Approval in the EU for Xarelto (rivaroxaban) for Patients with Coronary or Peripheral Artery Disease [Not intended for U.S. and UK Media]". Berlin. |
2018-08-24 |
| c-LEcta GmbH. (8/23/18). "Press Release: c-LEcta Lays Foundation for Further Growth and Closes Financing Round". Leipzig. |
2018-08-23 |
| Novaremed AG. (8/23/18). "Press Release: Novaremed Announces It Has Raised CHF 6 Million to Prepare for a Phase 2b Study in Diabetic Neuropathic Pain". Basel. |
2018-08-23 |
| BRAIN AG. (8/22/18). "Press Release: BRAIN AG Announces the Creation of SolasCure Ltd. to Continue Development of Aurase". Zwingenberg. |
2018-08-22 |
| Berlin Cures Holding AG. (8/22/18). "Press Release: Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy". Zug. |
2018-08-22 |
| Knauer Wissenschaftliche Geräte GmbH. (8/22/18). "Press Release: Easy to Use Mass Directed Purification with Single Quadrupole Mass Spectrometer". |
2018-08-22 |
| Evotec AG. (8/22/18). "Press Release: Evotec and Novo Nordisk Form Strategic Research Alliance in Diabetes and Obesity". Hamburg. |
2018-08-22 |
| GlucoMe Ltd.. (8/22/18). "Press Release: GlucoMe and Merck KGaA, Darmstadt, Germany to Collaborate on Digital Diabetes Management Project in Vietnam". Yarkona. |
2018-08-22 |
| Navamedic ASA. (8/21/18). "Press Release: Renews Multiple Key Distribution Agreements". Oslo. |
2018-08-21 |
| Medigene AG. (8/21/18). "Press Release: Medigene and Structured Immunity Announce Collaboration Aimed at Improving T Cell Receptor Development". Planegg. |
2018-08-21 |
| Roche. (8/20/18). "Press Release: China National Drug Administration Grants Rapid Approval of Roche’s Alecensa (alectinib) as a Treatment for ALK-positive Lung Cancer". Basel. |
2018-08-20 |
| Genedata AG. (8/20/18). "Press Release: Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D". San Francisco, CA. |
2018-08-20 |
| Tecan Group Ltd.. (8/16/18). "Press Release: Tecan Accelerates Broad Genomics Strategy with the Acquisition of NuGen Technologies". Männedorf. |
2018-08-16 |
| Tecan Group Ltd.. (8/16/18). "Press Release: H1 2018 – Tecan Posts Strong Increase in Sales, Driven by Growth in the Partnering Business". Männedorf. |
2018-08-16 |
| Mologen AG. (8/16/18). "Press Release: Mologen and Oncologie. Global Assignment and Co-development Agreement Relating to Mologen’s Lead Compound Lefitolimod". Berlin. |
2018-08-16 |
| BioNTech AG. (8/16/18). "Press Release: BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". Mainz & New York, NY. |
2018-08-16 |
| Stratec Biomedical AG. (8/15/18). "Press Release: Stratec Reports H1 2018 Figures and Adjusts Financial Guidance". Birkenfeld. |
2018-08-15 |
| Evotec AG. (8/14/18). "Press Release: Evotec Partner Haplogen Enters into Collaboration with Bayer". Hamburg. |
2018-08-14 |
| Haplogen GmbH. (8/14/18). "Press Release: Haplogen Enters into a Collaboration with Bayer". Vienna. |
2018-08-14 |
| Artios Pharma Ltd.. (8/10/18). "Press Release: Artios Pharma Announces $84 million (£65 million) Series B Financing. Financing Round Led by New Investors Andera Partners and LSP". |
2018-08-10 |
| Evotec AG. (8/9/18). "Press Release: Evotec AG Reports First Half-year 2018 Results and Corporate Updates". Hamburg. |
2018-08-09 |
| Merck KGaA. (8/9/18). "Press Release: Merck Reports Solid Organic Performance in Q2 2018". Darmstadt. |
2018-08-09 |
| Pieris Pharmaceuticals, Inc.. (8/9/18). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA. |
2018-08-09 |
| Mologen AG. (8/9/18). "Press Release: Mologen AG with Positive Developments in the First Half of 2018. Successful Financing Measures and Continuation of Clinical Studies". |
2018-08-09 |
| 4SC AG. (8/9/18). "Press Release: 4SC Provides Q2 and H1 2018 Update". Planegg-Martinsried. |
2018-08-09 |
| Consilium Strategic Communications Ltd.. (8/8/18). "Press Release: Consilium – H1 2018 Update". Munich. |
2018-08-08 |
| Epigenomics AG. (8/8/18). "Press Release: Epigenomics AG Announces 2018 Second Quarter and Six Month Financial Results". Berlin & San Diego, CA. |
2018-08-08 |
| MorphoSys AG. (8/8/18). "Press Release: MorphoSys and I-Mab Biopharma Announce China IND Submission of TJ202/MOR202". |
2018-08-08 |
| CRISPR Therapeutics AG. (8/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results". Zug & Cambridge, MA. |
2018-08-07 |
| BRAIN AG. (8/7/18). "Press Release: Frank Goebel, CFO of BRAIN AG, Has Asked the Supervisory Board for Early Termination of his Management Board Contract for Personal Reasons". Zwingenberg. |
2018-08-07 |
| Akouos. (8/7/18). "Press Release: Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing". Boston, MA. |
2018-08-07 |
| Boehringer Ingelheim. (8/6/18). "Press Release: Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis". Ingelhei |
2018-08-06 |
| Eppendorf AG. (8/3/18). "Press Release: First Half Year 2018 – Eppendorf with Broadbased Growth above Market Average". Hamburg. |
2018-08-03 |
| Roche. (8/3/18). "Press Release: PRIME Designation Granted by European Medicines Agency for RG6042 for Treatment of Huntington’s Disease". Basel. |
2018-08-03 |
| Boehringer Ingelheim. (8/2/18). "Press Release: Boehringer Ingelheim Launches the Initiative In Reach Africa to Address Key Healthcare Infrastructure and Access Priorities across Africa". Ingelheim. |
2018-08-02 |
| Bruker Corporation. (8/2/18). "Press Release: Bruker Reports Second Quarter 2018 Financial Results". Billerica, MA. |
2018-08-02 |
| Boehringer Ingelheim. (8/1/18). "Press Release: Boehringer Ingelheim Achieves Modest Growth in the First Half of 2018". Ingelheim. |
2018-08-01 |
| SiO2 Medical Products, Inc.. (8/1/18). "Press Release: BioNTech and SMP to Evaluate SMP’s Next Generation Technology for BioNTech Products". Auburn, AL. |
2018-08-01 |
| MorphoSys AG. (8/1/18). "Press Release: MorphoSys AG Reports Second Quarter 2018 Financial Results". Planegg. |
2018-08-01 |
| Qiagen N.V.. (8/1/18). "Press Release: Qiagen Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Faunch of Companion Diagnostics". Hilden & Tokyo. |
2018-08-01 |
| Mologen AG. (8/1/18). "Press Release: Dr Ignacio Faus Appointed as New CEO of Mologen AG". Berlin. |
2018-08-01 |
| Evotec AG. (7/31/18). "Press Release: Evotec Repays 50% of EUR 140 M Acquisition Loan". Hamburg. |
2018-07-31 |
| Marinomed Biotech AG. (7/31/18). "Press Release: Pascal Schmidt Appointed CFO as Vienna Based Biotech Firm Marinomed Strengthens Its Management Team – Company Reports Strong Growth". Vienna. |
2018-07-31 |
| Roche. (7/31/18). "Press Release: Roche Purchases Shares in Tender Offer for FMI". Basel. |
2018-07-31 |
| Qiagen N.V.. (7/30/18). "Press Release: Qiagen and Hamilton Launch New Collaboration to Improve Pre-analytical Sample Processing for QuantiFERON-TB Gold Plus". Germantown, MD & Hilden & Reno, NV. |
2018-07-30 |
| Novartis AG. (7/30/18). "Press Release: Novartis Marks a New Era for Migraine Patients with the EU Approval of Aimovig, a First-of-its-Kind Treatment Specifically Designed for Migraine Prevention". Basel. |
2018-07-30 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2011.jpg){kind=logo}
1 2 3 4 ... 97 98 99 
Date![Picture [iito] – Putting Information into Context 600x60px](/banner/iito-20181119-600-060-iito-business-intelligence-putting-information-into-context.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
